Innovent Biologics, Inc. (1801.HK)

HKD 36.2

(-0.82%)

Revenue Summary of Innovent Biologics, Inc.

Innovent Biologics, Inc.'s latest annual revenue in 2023 was 6.2 Billion CNY , up 36.21% from previous year.
Innovent Biologics, Inc.'s latest quarterly revenue in 2024 Q2 was 1.97 Billion CNY , down 0.0% from previous quarter.
Innovent Biologics, Inc. reported a annual revenue of 4.55 Billion CNY in annual revenue 2022, up 6.71% from previous year.
Innovent Biologics, Inc. reported a annual revenue of 4.26 Billion CNY in annual revenue 2021, up 11.08% from previous year.
Innovent Biologics, Inc. reported a quarterly revenue of 1.97 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Innovent Biologics, Inc. reported a quarterly revenue of 1.75 Billion CNY for 2023 Q3, up 29.72% from previous quarter.

Annual Revenue Chart of Innovent Biologics, Inc. (2023 - 2016)

Historical Annual Revenue of Innovent Biologics, Inc. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	6.2 Billion CNY	36.21%
2022	4.55 Billion CNY	6.71%
2021	4.26 Billion CNY	11.08%
2020	3.84 Billion CNY	266.94%
2019	1.04 Billion CNY	10953.34%
2018	9.47 Million CNY	-48.88%
2017	18.53 Million CNY	-42.3%
2016	32.12 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q1	1.97 Billion CNY	12.78%
2024 Q2	1.97 Billion CNY	0.0%
2023 Q3	1.75 Billion CNY	29.72%
2023 Q1	1.35 Billion CNY	16.61%
2023 Q2	1.35 Billion CNY	0.0%
2023 Q4	1.75 Billion CNY	0.0%
2023 FY	6.2 Billion CNY	36.21%
2022 Q2	1.11 Billion CNY	0.0%
2022 Q4	1.15 Billion CNY	0.0%
2022 FY	4.55 Billion CNY	6.71%
2022 Q3	1.15 Billion CNY	3.45%
2022 Q1	1.11 Billion CNY	-3.8%
2021 Q4	1.16 Billion CNY	0.0%
2021 Q3	1.16 Billion CNY	19.89%
2021 Q2	970.87 Million CNY	0.0%
2021 Q1	970.87 Million CNY	-32.1%
2021 FY	4.26 Billion CNY	11.08%
2020 FY	3.84 Billion CNY	266.94%
2020 Q4	1.42 Billion CNY	0.0%
2020 Q3	1.42 Billion CNY	190.55%
2020 Q2	492.1 Million CNY	0.0%
2020 Q1	492.1 Million CNY	40.2%
2019 FY	1.04 Billion CNY	10953.34%
2019 Q1	172.75 Million CNY	6754.14%
2019 Q3	351 Million CNY	103.18%
2019 Q4	351 Million CNY	0.0%
2019 Q2	172.75 Million CNY	0.0%
2018 Q1	2.21 Million CNY	-93.1%
2018 Q4	2.52 Million CNY	0.0%
2018 Q3	2.52 Million CNY	13.64%
2018 Q2	2.21 Million CNY	0.0%
2018 FY	9.47 Million CNY	-48.88%
2017 Q1	5.33 Million CNY	0.0%
2017 FY	18.53 Million CNY	-42.3%
2017 Q4	32.15 Million CNY	0.0%
2017 Q3	32.15 Million CNY	503.14%
2017 Q2	5.33 Million CNY	0.0%
2016 FY	32.12 Million CNY	0.0%

Peer Revenue Comparison of Innovent Biologics, Inc.

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	-1180.347%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	-16.596%